Product Overview: Clomid 50 Dragon Pharma
Clomid 50 Dragon Pharma is a selective estrogen receptor modulator (SERM) formulation containing clomiphene citrate as the active pharmaceutical ingredient. This non-steroidal compound functions as a competitive antagonist at estrogen receptors in specific tissue types while demonstrating agonist activity in others. Clomiphene citrate consists of two geometric isomers, with the trans-isomer (enclomiphene) primarily responsible for the anti-estrogenic effects observed in research models. Researchers at Stroid UK Shop frequently investigate this compound for its role in hypothalamic-pituitary-gonadal axis modulation studies.
Laboratory Research Applications
Scientists examine clomiphene citrate extensively in post cycle therapy research protocols where gonadotropin release patterns are studied. The compound’s mechanism involves antagonising estrogen receptors at the hypothalamic level, which subsequently influences luteinising hormone and follicle-stimulating hormone secretion in experimental models. Research institutions analyse its effects on hormone restoration timelines following exposure to various test compounds. Laboratory studies also investigate clomiphene’s tissue-selective properties, examining how it functions differently across reproductive, bone, and cardiovascular tissue samples. Comparative research with other SARMs and peptides helps researchers understand optimal recovery protocols in controlled environments.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Clomiphene Citrate |
| CAS Number | 50-41-9 |
| Molecular Formula | C₃₂H₃₆ClNO₈ |
| Molecular Weight | 598.08 g/mol |
| Formulation | Oral tablets |
| Concentration | 50mg per tablet |
| Storage Requirements | Room temperature, dry environment |
| Analytical Testing | HPLC verified purity |
Research Compliance Statement
This Clomid 50 Dragon Pharma formulation is manufactured exclusively for in-vitro laboratory research and experimental applications. The product is not intended for human consumption, therapeutic use, or any clinical applications outside controlled laboratory environments. Researchers must ensure proper laboratory protocols are followed when handling this compound. All studies should be conducted by qualified personnel in appropriately equipped research facilities with adequate safety measures and documentation procedures.
